menu
    • menu

    Company profile for Quell Therapeutics

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, ...
    At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, patients and payors, which have the promise of delivering transformational results for our patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quell Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Translation & Innovation Hub 84 Wood Lane London
    Telephone
    Telephone
    0207 096 9012
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quell-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quell-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quell Shows Early Efficacy of CAR-Tregs in Liver Transplant
    Quell Shows Early Efficacy of CAR-Tregs in Liver Transplant

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248049/0/en/Quell-Therapeutics-Demonstrates-Safety-Phenotypic-Stability-Durability-and-Early-Efficacy-with-Phenotype-Locked-CAR-Tregs-in-LIBERATE-Phase-1-2-Liver-Transplant-Study.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Quell Starts CHILL Phase 1/2 Trial for QEL-005-CAR-Treg Therapy
    Quell Starts CHILL Phase 1/2 Trial for QEL-005-CAR-Treg Therapy

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248058/0/en/Quell-Therapeutics-Initiates-CHILL-Phase-1-2-Trial-of-Novel-QEL-005-CAR-Treg-Therapy-in-Refractory-Rheumatoid-Arthritis-and-Systemic-Sclerosis-Following-UK-CTA-Approval.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Quell Halts Transplant Trial To Focus On 'Chill Not Kill' Treg
    Quell Halts Transplant Trial To Focus On 'Chill Not Kill' Treg

    05 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/quell-halts-liver-transplant-treg-trial-focus-preclinical-chill-not-kill-candidate

    FIERCE BIOTECH
    05 Feb 2026
    Share Share
    Quell Therapeutics To Present Positive QEL-005, CAR-Treg Data
    Quell Therapeutics To Present Positive QEL-005, CAR-Treg Data

    25 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/25/3174167/0/en/Quell-Therapeutics-to-Unveil-Promising-Data-for-QEL-005-a-Novel-CAR-Treg-Cell-Therapy-for-Complex-Autoimmune-Diseases-at-ACR-Convergence-2025.html

    GLOBENEWSWIRE
    25 Oct 2025
    Share Share
    Quell Therapeutics Forms Elite Scientific Advisory Board
    Quell Therapeutics Forms Elite Scientific Advisory Board

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139858/0/en/Quell-Therapeutics-Establishes-World-Class-Scientific-Advisory-Board.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    Quell Therapeutics Hits Milestone in CAR-Treg for IBD
    Quell Therapeutics Hits Milestone in CAR-Treg for IBD

    10 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/10/3096491/0/en/Quell-Therapeutics-Achieves-Key-Milestone-in-its-CAR-Treg-Cell-Therapy-Program-for-Inflammatory-Bowel-Disease.html

    GLOBENEWSWIRE
    10 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search